Skip to main content
See every side of every news story
Published • loading... • Updated

Novo says Wegovy injection lowers BMI and obesity rates in children in trial

Summary by CNBC
Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

CNBC broke the news in Englewood Cliffs, United States on Monday, November 16, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal